Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant
K Atsou, L Ereshefsky, M Brignone… - Expert Review of …, 2021 - Taylor & Francis
Introduction: Many patients with major depressive disorder (MDD) do not achieve remission
with their first antidepressant (AD), resulting in a high burden due to treatment failure …
with their first antidepressant (AD), resulting in a high burden due to treatment failure …
Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant
K Atsou, L Ereshefsky, M Brignone… - Expert review of …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction: Many patients with major depressive disorder (MDD) do not achieve remission
with their first antidepressant (AD), resulting in a high burden due to treatment failure …
with their first antidepressant (AD), resulting in a high burden due to treatment failure …
Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant.
K Atsou, L Ereshefsky, M Brignone… - Expert Review of …, 2021 - europepmc.org
Introduction: Many patients with major depressive disorder (MDD) do not achieve remission
with their first antidepressant (AD), resulting in a high burden due to treatment failure …
with their first antidepressant (AD), resulting in a high burden due to treatment failure …